Profound Medical Statistics
Want to see TSE:PRN full AI Analyst Report?
Profound Medical (PRN) Stock Statistics & Valuation Metrics
Total Valuation
Profound Medical has a market cap or net worth of CAD 388.24M. The enterprise value is CAD 267.99M.
- Market Cap
- CAD 388.24M
- Enterprise Value
- CAD 267.99M
Share Statistics
Profound Medical has 36,626,842 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 36,626,842
- Owned by Insiders
- 3.07%
- Owned by Institutions
- 26.94%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.10%.
- Return on Equity (ROE)
- -0.65
- Return on Assets (ROA)
- -0.31
- Return on Invested Capital (ROIC)
- -31.10%
- Return on Capital Employed (ROCE)
- -0.31
- Revenue Per Employee
- 101.11K
- Profits Per Employee
- -267.38K
- Employee Count
- 162
- Asset Turnover
- 0.12
- Inventory Turnover
- 0.58
Valuation Ratios
The current PE Ratio of Profound Medical is -8.07. Profound Medical’s PEG ratio is -0.22.
- PE Ratio
- -8.07
- PS Ratio
- 11.54
- PB Ratio
- 6.39
- Price to FCF
- -8.69
- Price to Operating Cash Flow
- -8.72
- PEG Ratio
- -0.22
Income Statement
In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.
- Revenue
- 16.38M
- Gross Profit
- 11.59M
- Operating Income
- -41.98M
- Pretax Income
- -43.06M
- Net Income
- -43.32M
- EBITDA
- -41.41M
- Earnings Per Share (EPS)
- -1.43
Cash Flow
In the last 12 months, operating cash flow was -31.14M and capital expenditures -179,087, giving a free cash flow of -31.32M billion.
- Operating Cash Flow
- -31.14M
- Free Cash Flow
- -31.32M
- Free Cash Flow per Share
- -0.86
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.51%
- Earnings Yield
- -11.88%
Stock Price Statistics
- Beta
- 1.61
- 52-Week Price Change
- 17.26%
- 50-Day Moving Average
- 8.86
- 200-Day Moving Average
- 9.21
- Relative Strength Index (RSI)
- 63.90
- Average Volume (3m)
- 15.71K
Important Dates
Profound Medical upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- ―
Financial Position
Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 7.09%
- Current Ratio
- 12.52
- Quick Ratio
- 11.17
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 1.33
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Profound Medical has paid 256.41K in taxes.
- Income Tax
- 256.41K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -7.35, with an EV/FCF ratio of -7.86.
- EV to Sales
- 10.44
- EV to EBITDA
- -7.35
- EV to Free Cash Flow
- -7.86
- EV to Operating Cash Flow
- -7.90
Balance Sheet
Profound Medical has CAD 33.34M in cash and marketable securities with CAD 7.36M in debt, giving a net cash position of CAD 25.98M billion.
- Cash & Marketable Securities
- CAD 33.34M
- Total Debt
- CAD 7.36M
- Net Cash
- CAD 25.98M
- Net Cash Per Share
- CAD 0.71
- Tangible Book Value Per Share
- CAD 1.16
Margins
Gross margin is 73.82%, with operating margin of -144.15%, and net profit margin of -136.86%.
- Gross Margin
- 73.82%
- Operating Margin
- -144.15%
- Pretax Margin
- -136.43%
- Net Profit Margin
- -136.86%
- EBITDA Margin
- -142.14%
- EBIT Margin
- -144.15%
Analyst Forecast
The average price target for Profound Medical is CAD 15.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- CAD 15.68
- Price Target Upside
- 47.92% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 64.70%
- EPS Growth Forecast
- 30.61%
Scores
- Smart Score
- 5
- AI Score
- 61
